Login / Signup
Haixu Xu
ORCID
Publication Activity (10 Years)
Years Active: 2022-2022
Publications (10 Years): 2
Top Topics
High Throughput Sequencing
Angiotensin Ii
Newly Diagnosed
Vascular Smooth Muscle Cells
Top Venues
Oxidative medicine and cellular longevity
The Journal of experimental medicine
</>
This page only lists publications with an associated author ORCID identifier.
Publications
</>
Lulu Guan
,
Feifei Wang
,
Mengjiao Wang
,
Songfeng Han
,
Zhaohai Cui
,
Shou-Min Xi
,
Haixu Xu
,
Shi-Peng Li
Downregulation of HULC Induces Ferroptosis in Hepatocellular Carcinoma via Targeting of the miR-3200-5p/ATF4 Axis.
Oxidative medicine and cellular longevity
2022 (2022)
Gaoyu Liu
,
Yingying Chen
,
Ying Wang
,
Xiaohui Deng
,
Qiang Xiao
,
Lijuan Zhang
,
Haixu Xu
,
Xu Han
,
Aihua Lei
,
Juan He
,
Xing Li
,
Yingjiao Cao
,
Pan Zhou
,
Chunhui He
,
Pei-Qiong Wu
,
Wen-Hui Jiang
,
Meizheng Tan
,
Chun Chen
,
Quan Yang
,
Liwei Lu
,
Kai Deng
,
Zhi Yao
,
Jie Zhou
Angiotensin II enhances group 2 innate lymphoid cell responses via AT1a during airway inflammation.
The Journal of experimental medicine
219 (3) (2022)